Goldman Sachs Group restated their neutral rating on shares of Evonik Industries (FRA:EVK) in a research note issued to investors on Monday morning, Borsen Zeitung reports.
Several other analysts have also recently commented on EVK. DZ Bank cut from a buy rating to a hold rating in a report on Friday, June 14th. Warburg Research set a €60.00 ($69.77) target price on Compugroup Medical and gave the stock a neutral rating in a report on Tuesday, May 7th. Morgan Stanley set a $165.00 target price on Caterpillar and gave the stock a buy rating in a report on Wednesday, April 10th. UBS Group cut CR AGRICOLE S A/ADR from a buy rating to a neutral rating in a report on Monday, May 20th. Finally, Kepler Capital Markets set a €14.00 ($16.28) price target on alstria office REIT and gave the company a neutral rating in a research note on Tuesday, May 7th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and ten have issued a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus price target of €30.90 ($35.93).
Shares of EVK stock opened at €24.93 ($28.99) on Monday. The business’s fifty day simple moving average is €24.81. Evonik Industries has a 52 week low of €26.78 ($31.14) and a 52 week high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Recommended Story: Consumer behavior in bull markets
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.